Please login to the form below

Not currently logged in
Email:
Password:

BrightGene

This page shows the latest BrightGene news and features for those working in and with pharma, biotech and healthcare.

UPDATED: Gilead drops remdesivir’s orphan drug designation

UPDATED: Gilead drops remdesivir’s orphan drug designation

Chinese pharma company BrightGene also alleged that it had successfully copied remdesivir and had plans to manufacture a generic version of the drug. ... The SSE said that BrightGene had not gained approval from China’s drug regulator to manufacture

Latest news

More from news
Approximately 1 fully matching, plus 4 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Aptus Health

Aptus Health is dedicated to advancing health engagement. The company offers end-to-end digital health engagement solutions spanning all areas of...

Latest intelligence

Our Top 5 Pharma Picks From Cannes Lions
Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
The Evolving Role of the Sales Rep
The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
Measure your omnichannel maturity with our new tool
Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....